CN1064405C - Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm - Google Patents
Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm Download PDFInfo
- Publication number
- CN1064405C CN1064405C CN96116311A CN96116311A CN1064405C CN 1064405 C CN1064405 C CN 1064405C CN 96116311 A CN96116311 A CN 96116311A CN 96116311 A CN96116311 A CN 96116311A CN 1064405 C CN1064405 C CN 1064405C
- Authority
- CN
- China
- Prior art keywords
- silkworm
- gene
- recombinant
- site
- sjc28
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000255789 Bombyx mori Species 0.000 title claims abstract description 44
- 241001442514 Schistosomatidae Species 0.000 title claims abstract 4
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 102000005720 Glutathione transferase Human genes 0.000 title abstract description 8
- 108010070675 Glutathione transferase Proteins 0.000 title abstract description 8
- 230000009897 systematic effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 241000700605 Viruses Species 0.000 claims abstract description 14
- 230000000694 effects Effects 0.000 claims abstract description 9
- 210000000087 hemolymph Anatomy 0.000 claims description 16
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 8
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 claims description 7
- 108020004414 DNA Proteins 0.000 claims description 7
- 229920000936 Agarose Polymers 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 229960003180 glutathione Drugs 0.000 claims description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 5
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 108091026890 Coding region Proteins 0.000 claims description 2
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 claims description 2
- 239000000020 Nitrocellulose Substances 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 239000013504 Triton X-100 Substances 0.000 claims description 2
- 229920004890 Triton X-100 Polymers 0.000 claims description 2
- 229920001220 nitrocellulos Polymers 0.000 claims description 2
- 230000006798 recombination Effects 0.000 claims description 2
- 238000005215 recombination Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 206010061217 Infestation Diseases 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 240000000249 Morus alba Species 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 238000004264 monolayer culture Methods 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 230000008521 reorganization Effects 0.000 claims 1
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- 238000011218 seed culture Methods 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 6
- 241000382353 Pupa Species 0.000 abstract description 2
- 230000000890 antigenic effect Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 10
- 241000242677 Schistosoma japonicum Species 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 201000004409 schistosomiasis Diseases 0.000 description 5
- 238000010367 cloning Methods 0.000 description 4
- 241000519995 Stachys sylvatica Species 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 2
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 101710182846 Polyhedrin Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920006051 Capron® Polymers 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 241000242680 Schistosoma mansoni Species 0.000 description 1
- 102100026503 Sperm mitochondrial-associated cysteine-rich protein Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
本发明涉及多肽药物的生产工艺,具体涉及重组日本血吸虫谷胱甘肽-转移酶的生产工艺。The invention relates to a production process of polypeptide medicine, in particular to a production process of recombinant Schistosoma japonicum glutathione-transferase.
谷胱甘肽-转移酶(GST)是抗血吸虫病的首选疫苗之一,在国内外已广泛研究。法国巴斯德研究院Capron实验室最早报道了编码曼氏血吸虫28kDaGST(Sm28)的克隆和在大肠杆菌中的表达,重组抗原在动物免疫试验中获得较高的保护力和减虫卵效果,并证明重组Sm28具有GTS活力,见Nature(1987)326:149、ParasiteImmunol(1991)13:473和EMBOJ(1988)7:465报道。Sm28和日本血吸虫28kDaGST(Sj28)的核甘酸和氨基酸序列具有77%的同源性,但两者含T细胞抗原决定簇功能区有所不同。澳大利亚Mitchell实验室进行了日本血吸虫菲律宾株26 kDa-GST(SjP26)的克隆、重组和表达工作,见ProNatl Acad Sci USA(1986)83:8703与MOL BiochemParasitol(1988)27:249报道,但其免疫效果不稳定,而且Sj28和Sj26截然不同,氨基酸序列同源性不到20%,见Trans RSOC Trop MedHyg(1988)82:885与Mol Biothem Parasitol(1990)40:23报道。Glutathione-transferase (GST) is one of the first-choice vaccines against schistosomiasis, and has been extensively studied at home and abroad. The Capron laboratory of the Institut Pasteur in France first reported the cloning and expression of Schistosoma mansoni 28kDaGST (Sm28) in Escherichia coli. Proof that recombinant Sm28 has GTS activity, see Nature (1987) 326:149, Parasite Immunol (1991) 13:473 and EMBOJ (1988) 7:465 reports. The nucleotide and amino acid sequences of Sm28 and Schistosoma japonicum 28kDaGST (Sj28) have 77% homology, but the two have different T cell antigenic determinant functional regions. Australian Mitchell laboratory carried out the cloning, recombination and expression work of Schistosoma japonicum Philippine strain 26 kDa-GST (SjP26), see ProNatl Acad Sci USA (1986) 83: 8703 and MOL Biochem Parasitol (1988) 27: 249 report, but its immune The effect is unstable, and Sj28 and Sj26 are completely different, and the amino acid sequence homology is less than 20%, see Trans RSOC Trop MedHyg (1988) 82:885 and Mol Biothem Parasitol (1990) 40:23 reports.
本发明的目的在于克服上述不足之处,研究开发以家蚕为宿主,替代大肠杆菌等其它表达系统,在家蚕幼虫(或蛹)中高效表达具有酶活性的SjC28kDaGST。The purpose of the present invention is to overcome the above disadvantages, research and develop silkworm as a host, instead of other expression systems such as Escherichia coli, and efficiently express SjC28kDaGST with enzymatic activity in silkworm larvae (or pupae).
本发明提供了重组日本血吸虫谷胱甘肽-转移酶的一种新的生产工艺。The invention provides a new production process of recombinant Schistosoma japonicum glutathione-transferase.
本发明的工艺是利用家蚕系统生产重组日本血吸虫谷胱甘肽S-转移酶。The technology of the invention is to use the silkworm system to produce recombinant schistosoma japonicum glutathione S-transferase.
本发明的生产工艺具体包括下列步骤:(见图1)Production technique of the present invention specifically comprises the following steps: (see Fig. 1)
图1 转移质粒SjC28-pBacPAK8的构建Figure 1 Construction of transfer plasmid SjC28-pBacPAK8
SjC28基因; 融合基因SjC28 gene; fusion gene
AcNPV旁侧序列MCS,多克隆位点;Tac,Tac启动子;Ph多角体启动子。 AcNPV flanking sequence MCS, multiple cloning site; Tac, Tac promoter; Ph polyhedron promoter.
(1)含SjC28kDaGST基因的重组家蚕核型多角体病毒Bm-Sj28的构建;SjC28kDaGST基因编码区为636bp,编码211个氨基酸,基因5′端Bam HI识别序列ATG相隔2bp,由于pBacPAK8多克隆位点下游的旁侧序列中存在仅有的HindⅢ位点,而SjC28基因的21bp处亦有一个HindⅢ位点,所以当SjC28基因以Bam HI、KpnI定向装入pBacPAK8后,重组质粒经HindⅢ酶切电泳,显示出5Kb和1.1Kb两种片段,非重组质粒则只出现5.1Kb一种片段,扩增纯化后的重组转移质粒DNA和酶切线性化的BmNPV DNA在脂质体(Lipofectin)作用下共转染单层培养的家蚕BmN细胞,进行细胞内DNA同源重组,27℃培养1周后,收集上清液,分别作10-3、5×10-4和10-4稀释,感染1×105细胞1小时,铺上含0.2mg/lX-gal的低熔点琼脂糖27℃4天后,出现蓝、白空斑,挑取多个白斑于24孔培养板(1×104细胞/孔),于27℃培养72小时,收集细胞进行SDS-PAGE(12%分离胶),350mA、1小时电转移至硝酸纤维素膜(NC)上,用大肠杆菌表达的SjC28kDaGST免疫绵羊血清(r-SjC28ISS)筛选出阳性重组病毒空斑。然后进行第二轮空斑分析,得到纯化的重组病毒Bm-Sj28,滴度为7×106PFU/ml;SjC28 KDaGST基因除一个HindⅢ外位点,在90bp、111bp各有一个Eco RI位点,503bp有一个BclⅠ位点,Bm-Sj28经这三种酶酶切后,均能于[α-32P]-dCTP标记的Sjc28探针杂交,进一步证明SjC基因插入到BmNPV DNA中的正确位置(见图2)。(1) Construction of the recombinant silkworm nuclear polyhedrosis virus Bm-Sj28 containing the SjC28kDaGST gene; the SjC28kDaGST gene coding region is 636bp, encoding 211 amino acids, and the Bam HI recognition sequence ATG at the 5' end of the gene is separated by 2bp, due to the multiple cloning sites of pBacPAK8 There is only a HindⅢ site in the downstream side sequence, and there is also a HindⅢ site at 21 bp of the SjC28 gene, so when the SjC28 gene is loaded into pBacPAK8 with Bam HI and KpnI, the recombinant plasmid is subjected to HindⅢ digestion and electrophoresis. Two fragments of 5Kb and 1.1Kb were shown, and only one fragment of 5.1Kb appeared in the non-recombinant plasmid. Co-transfect monolayer cultured silkworm BmN cells, carry out intracellular DNA homologous recombination, and culture at 27°C for 1 week, collect the supernatant, make 10 -3 , 5×10 -4 and 10 -4 dilutions respectively, and infect 1 ×10 5 cells for 1 hour, spread low-melting point agarose containing 0.2 mg/lX-gal at 27°C for 4 days, blue and white spots appeared, pick multiple white spots on 24-well culture plate (1×104 cells/ Wells), cultured at 27°C for 72 hours, collected cells for SDS-PAGE (12% gel), 350mA, 1 hour electrotransfer to nitrocellulose membrane (NC), immune sheep serum (r -SjC28ISS) to screen out positive recombinant virus plaques. Then the second round of plaque analysis was carried out to obtain the purified recombinant virus Bm-Sj28 with a titer of 7×10 6 PFU/ml; the SjC28 KDaGST gene had an Eco RI site at 90bp and 111bp respectively except for a HindⅢ site. There is a BclⅠ site at 503bp, and Bm-Sj28 can be hybridized with [α- 32P ]-dCTP-labeled Sjc28 probe after digested by these three enzymes, which further proves that the SjC gene is inserted into the correct position of BmNPV DNA ( See Figure 2).
图2:重组病毒Bm-Sj28的Southern杂交Figure 2: Southern hybridization of recombinant virus Bm-Sj28
(2)SjC28kDaGST基因在家蚕幼虫(或蛹)中的高效表达;(2) High expression of SjC28kDaGST gene in silkworm larvae (or pupae);
纯化的Bm-Sj28以200ul(感染指数Mol=1.4PFU/细胞)感染×106BmN细胞,27℃培养3天后,收集上清液作为毒种,桑叶饲养的家蚕5龄起蚕(或蛹),在节间膜下注射10ul(7×104PFU/蚕)重组病毒,于感染后第4日分别收集血淋巴和去除中肠的蚕体组织;见图3,图3是家蚕幼虫血淋巴中表达SjC28的SDS-PAGE图谱和蛋白质免疫印迹(Western Blotting)分析。Purified Bm-Sj28 was used to infect ×10 6 BmN cells with 200ul (infection index Mol=1.4PFU/cell), cultured at 27°C for 3 days, and the supernatant was collected as virus seeds. Pupa), inject 10ul (7×10 4 PFU/silkworm) recombinant virus under the intersegmental membrane, and collect the hemolymph and remove the silkworm body tissue in the midgut on the 4th day after infection; see Figure 3, Figure 3 is silkworm larvae SDS-PAGE pattern and Western Blotting analysis of SjC28 expressed in hemolymph.
其中1-4:感染Bm-Sj28的家蚕血淋巴(感染后第2至第5日),Among them 1-4: hemolymph of silkworm infected with Bm-Sj28 (2nd to 5th day after infection),
5-6:感染BmNPV的家蚕血淋巴(感染后第2、第4日)5-6: Bombyx mori hemolymph infected with BmNPV (2nd and 4th day after infection)
7-8:健康家蚕血淋巴(第2、第5日)7-8: Healthy silkworm hemolymph (
(3)从家蚕血淋巴和组织中分离纯化SjC28kDaGST;(3) Separation and purification of SjC28kDaGST from silkworm hemolymph and tissue;
将上述步骤得到的家蚕血淋巴和组织加入事先用PBST(含1% Triton X-100的PH7.2PBS)平衡的谷胱甘肽琼脂糖亲和层析柱,缓缓循环3-5次,然后依次用PBST和PBS充分洗柱,最后用PH9.1,50mmol/L Tris-7mmol GSH洗脱,收集各组份。见图4,图4是SDS-PAGE纯化图谱。The silkworm hemolymph and tissues obtained in the above steps were added to a glutathione agarose affinity chromatography column equilibrated with PBST (pH7.2PBS containing 1% Triton X-100) in advance, circulated slowly for 3-5 times, and then The column was thoroughly washed with PBST and PBS in turn, and finally eluted with pH 9.1, 50mmol/L Tris-7mmol GSH, and all fractions were collected. See Figure 4, Figure 4 is the SDS-PAGE purification profile.
其中H:家蚕幼虫血淋巴的纯化产物,Wherein H: the purified product of silkworm larval hemolymph,
T:家蚕幼虫组织中的纯化产物,T: Purified product from Bombyx mori larvae tissue,
A:家蚕幼虫血淋巴或组织匀浆上清,A: Bombyx mori larva hemolymph or tissue homogenate supernatant,
B:过柱后的流出液,B: The effluent after passing through the column,
1-10或1-7;各洗脱组份。1-10 or 1-7; each elution fraction.
本发明工艺中含SjC28基因的质粒pTrcHiSB由英国伦敦大学卫生和热带医学院医学寄生虫系Huggins M.C博士惠赠,转移质粒pBacPAK8(clontech公司产品)是带多角体基因启动子的非融合蛋白转移载体。感染Sj28KDaGST的家蚕血淋巴和组织中纯化得到的SjC28kDaGST能和不同稀释度的r-SJC28ISS起显著的免疫结合反应,证明家蚕中表达的SjC28kDaGST具有较强的日本血吸虫28kD GST抗原性。初步的小鼠免疫保护性试验结果表明,家蚕表达的SjC28kDaGST在BALB/c小鼠中诱导了17.26%的减虫率,第6周粪便减卵率达到85.38%。The plasmid pTrcHiSB containing the SjC28 gene in the process of the present invention was obtained by Huggins M. Donated by Dr. C, the transfer plasmid pBacPAK8 (product of clontech company) is a non-fusion protein transfer vector with polyhedrin gene promoter. SjC28kDaGST purified from the hemolymph and tissues of silkworms infected with Sj28KDaGST can have significant immunological binding reactions with different dilutions of r-SJC28ISS, which proves that SjC28kDaGST expressed in silkworms has strong antigenicity to Schistosoma japonicum 28kD GST. The results of the preliminary immune protection test in mice showed that SjC28kDaGST expressed by silkworm induced a 17.26% worm reduction rate in BALB/c mice, and the fecal egg reduction rate reached 85.38% at the sixth week.
用本发明工艺生产重组日本血吸虫谷胱甘肽S-转移酶通过Southern杂交鉴定。The recombinant Schistosoma japonicum glutathione S-transferase produced by the process of the invention is identified by Southern hybridization.
用本发明工艺生产重组日本血吸虫谷胱甘肽S-转移酶的特性测定结果如下:按文献方法(Nethodes in Enzymology(1985)113:499)进行,总反应体积为1ml,其中PH6.0,0.1mol/L磷酸钠缓冲液880ul,底物GSH和2、4-二硝基氯苯(CDNB)终浓度为1mmol/l,各取20ul样品进行测定,25℃反应1分钟,以不加样品的底物缓冲液作空白对照,于751分光光度计测定OD340,然后换算成比活力。The characteristic measurement result of producing recombinant Schistosoma japonicum glutathione S-transferase with process of the present invention is as follows: Carry out by literature method (Nethodes in Enzymology (1985) 113:499), total reaction volume is 1ml, wherein PH6.0,0 .1mol/L sodium phosphate buffer solution 880ul, the final concentration of substrate GSH and 2,4-dinitrochlorobenzene (CDNB) is 1mmol/l, take 20ul samples each for determination, react at 25°C for 1 minute, without adding samples The substrate buffer solution was used as a blank control, and the OD 340 was measured with a 751 spectrophotometer, and then converted into specific activity.
(2)抗原性测定:按本实验室建立的方法进行(中国兽医科技(1991)21:42),纯化SjC28以5ug/ml浓度包被96孔酶标板,4℃过夜,PBST(含0.05%Tween-20的PH7.2PBS)洗涤后,2%牛血清白蛋白37℃封闭1小时,PBST洗涤后,加入从1∶50开始对倍稀释的r-SjC28ISS,共作12个稀释度,重复2孔,37℃作用2小时,PBST洗涤后加入1∶12000稀释的辣根过氧化物酶标记抗绵羊IgG,37℃反应1小时,PBST洗涤后进行0.1%邻苯二胺底物溶液显色,最后用BIO-TEK312自动酶标仪测定OD490。(2) Determination of antigenicity: according to the method established by our laboratory (Chinese Veterinary Science and Technology (1991) 21:42), the purified SjC28 was coated with 96-well microtiter plate at a concentration of 5ug/ml, overnight at 4°C, PBST (containing 0 .05% Tween-20 pH7.2PBS) after washing, 2% bovine serum albumin at 37 ℃ for 1 hour, after washing with PBST, add r-SjC28ISS starting from 1:50, making 12 dilutions in total , repeat for 2 wells, act at 37°C for 2 hours, add horseradish peroxidase-labeled anti-sheep IgG diluted 1:12000 after washing with PBST, react at 37°C for 1 hour, wash with PBST and carry out 0.1% o-phenylenediamine substrate The solution was developed for color development, and finally the OD 490 was measured with a BIO-TEK312 automatic microplate reader.
(3)小鼠免疫保护性试验:6周龄雌性BALB/c小鼠购自中科院上海细胞研究所实验动物房。纯化SjC28kDaGST平均分三次免疫小鼠,第一次结合弗氏完全佐剂(CFA)注射小鼠脚垫和背部皮下,2周后结合弗氏不完全佐剂(IFA)注射小鼠背部皮下,2周后肌肉注射加强免疫,第三次免疫后1周,每只小鼠经腹部皮肤感染日本血吸虫尾蚴40条(本组钉螺房提供)。以弗氏佐剂组为对照组,感染后第6周收集小鼠粪便,计算粪便减卵率;感染后第7周解剖小鼠,用门静脉灌注术收集血吸虫成虫,计算减虫率。 (3) Mice immune protection test: 6-week-old female BALB/c mice were purchased from the experimental animal room of Shanghai Institute of Cell Research, Chinese Academy of Sciences. The purified SjC28kDaGST was averagely divided into three times to immunize the mice. The first time combined with Freund's complete adjuvant (CFA) to inject the mice's foot pads and back subcutaneously, and after 2 weeks, combined with Freund's incomplete adjuvant (IFA) to inject the mouse back subcutaneously. One week later, intramuscular injection was given to boost the immunization. One week after the third immunization, each mouse was infected with 40 cercariae of Schistosoma japonicum (provided by the snail house of this group) through the abdominal skin. The Freund's adjuvant group was used as the control group. The feces of the mice were collected at 6 weeks after infection, and the fecal egg reduction rate was calculated; the mice were dissected at the 7th week after infection, and adult schistosomes were collected by portal vein perfusion, and the rate of worm reduction was calculated.
上述结果表明:本发明构建的重组家蚕核型多角体病毒Bm-Sj28,多角体蛋白基因被SjC28kDaGST结构基因替代,位于BmNPV强大的多角体基因启动子控制下,在家蚕幼虫中,随着重组病毒的感染和复制,SjC28kDaGST得到高效表达,表达产物通过简便的一步法纯化得到SDS-PAGE电泳纯产物,其纯度能够满足家畜血防疫苗的要求,这是一条简便可行的生产工艺。与利用大肠杆菌系统表达的SjC28kDaGST相比:一条家蚕的纯化SjC28kDaGST产量相当于50ml以上大肠杆菌培养物;GST比活力相当(大肠杆菌表达产物3.94umol/min.mg);抗原性高近1倍(大肠杆菌表达产物对r-SjC28ISS反应的最高OD值为1.5);对小鼠的保护力,则与大肠杆菌表达的SjC28kDaGST(25-31%)及虫体提纯天然GST的保护力相近(中国兽医寄生虫病(1996)4:5),而粪便减卵率则高达85.38%。曾有动物试验表明,重组或天然GST虽然减虫效果不理想,但减卵率较高(ParasiteImmunol(1991)13:473;(1993)15:383)。因为虫卵是血吸虫传播的重要环节,所以大幅度降低宿主粪便中的虫卵排出数对控制血吸虫病有着非常重要的实际意义。另外,用大肠杆菌系统表达的产物是融合蛋白,而用BmNPV系统表达的是非融合蛋白,因此更接近于天然GST的空间构象。家蚕易于饲养,生产成本低,近年建立的家蚕人工饲养技术,为大规模工业化无菌生产提供了条件,利用BmNPV-家蚕系统生产血吸虫病疫苗无疑具有广阔前景和经济效益。The above results show that: in the recombinant silkworm nuclear polyhedrosis virus Bm-Sj28 constructed by the present invention, the polyhedrin gene is replaced by the SjC28kDaGST structural gene, which is located under the control of the powerful polyhedrosis gene promoter of BmNPV. In silkworm larvae, along with the recombinant virus SjC28kDaGST was highly expressed, and the expression product was purified by a simple one-step method to obtain a pure product by SDS-PAGE electrophoresis. The purity can meet the requirements of livestock schistosomiasis vaccines. This is a simple and feasible production process. Compared with the SjC28kDaGST expressed in the E. coli system: the purified SjC28kDaGST output of a silkworm is equivalent to more than 50ml of E. coli culture; the specific activity of GST is equivalent (3.94umol/min.mg of E. coli expression product); the antigenicity is nearly 1 times higher (The highest OD value of Escherichia coli expression product to r-SjC28ISS reaction is 1.5); the protective power to mice is similar to that of SjC28kDaGST (25-31%) expressed in Escherichia coli and the natural GST purified from parasites (Chinese Veterinary Parasitic Diseases (1996) 4:5), while the egg reduction rate in feces is as high as 85.38%. Animal experiments have shown that although the effect of recombinant or natural GST is not satisfactory, the egg reduction rate is higher (ParasiteImmunol (1991) 13:473; (1993) 15:383). Because eggs are an important link in the transmission of schistosomiasis, it is of great practical significance to greatly reduce the number of eggs excreted in the host's feces to control schistosomiasis. In addition, the product expressed by the E. coli system is a fusion protein, while the product expressed by the BmNPV system is a non-fusion protein, so it is closer to the spatial conformation of the natural GST. Bombyx mori is easy to raise and the production cost is low. The artificial breeding technology of silkworm established in recent years has provided conditions for large-scale industrial aseptic production. The production of schistosomiasis vaccine using the BmNPV-bombyx mori system undoubtedly has broad prospects and economic benefits.
实例1、转移质粒SjC28-pBacPAK8构建Example 1, construction of transfer plasmid SjC28-pBacPAK8
将SjC28kDaGST基因以BumHI、KpnI定向装入pBacPAK8,重组质粒经HindⅢ酶切电泳,显示出5Kb和1.1Kb两种片段,非重组质粒只有5.1Kb一种片段。重组转移质粒DNA和酶切线性化的BmNPV DNA在Lipofetin作用下共转染单层培养家蚕BmN细胞,进行细胞内同源重组。27℃培养1周后,收集上清分别作10-3、5×10-4和10-4稀释,感染1×106BmN细胞1小时,铺上含0.2mg/ml X-gal的低熔点琼酯糖,27℃4天后挑取20个白斑于24孔培养板(1×104细胞/孔),27℃培养72小时,收集细胞进行SDS-PAGE(12%分离胶)和Western Blotting,应用r-SjC28ISS筛选到19个阳性重组病毒空斑,再进行第二轮空斑分析,得到纯化的重组病毒Bm-Sj28,滴度为7×106PFU/ml。The SjC28kDaGST gene was oriented into pBacPAK8 with BumHI and KpnI, and the recombinant plasmid was subjected to HindⅢ digestion and electrophoresis, showing two fragments of 5Kb and 1.1Kb, and only one fragment of 5.1Kb in the non-recombinant plasmid. Recombinant transfer plasmid DNA and enzyme-digested linearized BmNPV DNA were co-transfected into monolayer cultured BmN cells of silkworm under the action of Lipofetin for intracellular homologous recombination. After culturing at 27°C for 1 week, collect the supernatant and make dilutions of 10 -3 , 5×10 -4 and 10 -4 respectively, infect 1×10 6 BmN cells for 1 hour, and spread the low-lying medium containing 0.2 mg/ml X-gal Melting point agarose, after 4 days at 27°C, pick 20 white spots on a 24-well culture plate (1×10 4 cells/well), culture at 27°C for 72 hours, collect cells for SDS-PAGE (12% separating gel) and Western Blotting , 19 positive recombinant virus plaques were screened by r-SjC28ISS, and the second round of plaque analysis was performed to obtain purified recombinant virus Bm-Sj28 with a titer of 7×10 6 PFU/ml.
实例2、SjC28kDaGST基因在家蚕幼虫(或蛹)中的高效表达及纯化。Example 2. High-efficiency expression and purification of SjC28kDaGST gene in silkworm larvae (or pupae).
5龄家蚕幼虫(中国农科院蚕业研究所提供),品系为57A.57B×24.46,以7×104PFU/蚕的剂量感染重组病毒,第4天剪去腹足,收集血淋巴和去除中肠的家蚕组织,分别用谷胱甘肽琼脂糖亲和层析柱纯化,经Folin-酚法(JBiol Chem(1951)193:265)测定计算,以每条家蚕得0.35ml血淋巴计,每条家蚕血淋巴中得纯化SjC28kDaGST 1.66mg,GST比活力为3.98umol/min.mg;整条家蚕组织平均以0.8g计(湿重),可得纯化SjC28kDaGST 4.03mg,GST比活力为3.74umol/min.mg。5th instar silkworm larvae (provided by the Institute of Sericulture, Chinese Academy of Agricultural Sciences), strain 57A. 57B×24.46, infected with the recombinant virus at a dose of 7×10 4 PFU/silkworm, cut off the gastropods on the 4th day, collected the hemolymph and removed the silkworm tissues from the midgut, and used glutathione agarose affinity layer respectively Purified by column analysis, measured and calculated by Folin-phenol method (JBiol Chem (1951) 193:265), based on 0.35ml hemolymph obtained from each silkworm, 1.66mg of purified SjC28kDaGST was obtained in each silkworm hemolymph, GST specific activity It is 3.98umol/min. mg; the average whole silkworm tissue is 0.8g (wet weight), and the purified SjC28kDaGST can be 4.03mg, and the specific activity of GST is 3.74umol/min. mg.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96116311A CN1064405C (en) | 1996-04-08 | 1996-04-08 | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96116311A CN1064405C (en) | 1996-04-08 | 1996-04-08 | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1162017A CN1162017A (en) | 1997-10-15 |
CN1064405C true CN1064405C (en) | 2001-04-11 |
Family
ID=5123426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96116311A Expired - Fee Related CN1064405C (en) | 1996-04-08 | 1996-04-08 | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1064405C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101481702B (en) * | 2009-01-22 | 2013-05-01 | 天津耀宇生物技术有限公司 | Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
CN113045671A (en) * | 2021-01-29 | 2021-06-29 | 长春万成生物电子工程有限公司 | Recombinant antigen for detecting schistosoma japonicum, preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85104701A (en) * | 1984-06-21 | 1986-12-17 | 第一制药株式会社 | Produce the method for useful matter |
CN86107784A (en) * | 1985-11-14 | 1987-06-03 | 第一制药株式会社 | method for producing peptide |
CN87104489A (en) * | 1986-05-19 | 1988-05-04 | 希巴-盖吉股份公司 | Herbicide tolerant plants containing glutathione S-transferase gene |
CN1096541A (en) * | 1994-01-24 | 1994-12-21 | 南京大学 | Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering |
-
1996
- 1996-04-08 CN CN96116311A patent/CN1064405C/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85104701A (en) * | 1984-06-21 | 1986-12-17 | 第一制药株式会社 | Produce the method for useful matter |
CN86107784A (en) * | 1985-11-14 | 1987-06-03 | 第一制药株式会社 | method for producing peptide |
CN87104489A (en) * | 1986-05-19 | 1988-05-04 | 希巴-盖吉股份公司 | Herbicide tolerant plants containing glutathione S-transferase gene |
CN1096541A (en) * | 1994-01-24 | 1994-12-21 | 南京大学 | Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering |
Also Published As
Publication number | Publication date |
---|---|
CN1162017A (en) | 1997-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4870023A (en) | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides | |
CN1161458C (en) | Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing same | |
US5516657A (en) | Baculovirus vectors for expression of secretory and membrane-bound proteins | |
EP0566579B1 (en) | Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions | |
CN101307317B (en) | Method for preparing rabies virus antigen | |
AU1717688A (en) | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides | |
US5229293A (en) | Recombinant baculovirus | |
GB2463783A (en) | A method for preparing antigens of foot-and-mouth disease virus | |
US5041379A (en) | Heliothis expression systems | |
CN1064405C (en) | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm | |
JPH0365191A (en) | Spheroidine isolated dna and recombinant insect pox virus expression vector | |
US5194381A (en) | Feline interferon and process for production thereof | |
CN102311957B (en) | Hydatidovis soluble antigen preparation method and product thereof | |
CN111607615B (en) | Preparation method of porcine epidemic diarrhea and porcine transmissible gastroenteritis virus disease bivalent subunit vaccine | |
Liu et al. | Preparation of ChIL-2 and IBDV VP2 fusion protein by baculovirus expression system | |
KR20010043627A (en) | Recombinant Baculovirus-Based Insecticides | |
CN102321634A (en) | Preparation method of mink enteritis parvovirus empty capsid antigen particles | |
Grausz et al. | Messenger RNA extracted from Schistosoma mansoni larval forms codes for parasite antigens when translated in vitro | |
CN1158385C (en) | Clone of Japanese schistosome fatty acid-binding protein gene and its expression in Bombyx mori system | |
JPH06500990A (en) | new protein | |
CN1375500A (en) | Thymic peptide fusion protein as one new interferon and its prepn. and use | |
JP2941859B2 (en) | Method for producing HA protein | |
WO2017119762A1 (en) | Method for mass producing plant-derived osmotin protein by using insect cells | |
JPS63500637A (en) | recombinant virus | |
CN1637138A (en) | Silkworm nuclear polyhedron virus and its prepn process and application in gene expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |